Market closedNon-fractional
Globus Medical/GMED
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Globus Medical
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.
Ticker
GMED
Sector
Healthcare
Trading on
NYSE
Industry
Health Care Equipment and Supplies
Headquarters
Audubon, United States
Employees
5,000
Website
www.globusmedical.com
Globus Medical Metrics
BasicAdvanced
$9.7B
Market cap
131.97
P/E ratio
$0.54
EPS
1.15
Beta
-
Dividend rate
Price and volume
Market cap
$9.7B
Beta
1.15
Financial strength
Current ratio
2.325
Quick ratio
1.233
Long term debt to equity
2.297
Total debt to equity
13.418
Interest coverage (TTM)
157.83%
Management effectiveness
Return on assets (TTM)
5.27%
Return on equity (TTM)
2.28%
Valuation
Price to earnings (TTM)
131.966
Price to revenue (TTM)
4.605
Price to book
2.47
Price to tangible book (TTM)
6.12
Price to free cash flow (TTM)
57.627
Growth
Revenue change (TTM)
77.59%
Earnings per share change (TTM)
-72.28%
3-year revenue growth (CAGR)
31.98%
3-year earnings per share growth (CAGR)
-23.25%
What the Analysts think about Globus Medical
Analyst Ratings
Majority rating from 16 analysts.
Globus Medical Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$607M
-1.61%
Net income
-$7.1M
-147.33%
Profit margin
-1.17%
-148.15%
Globus Medical Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.63
$0.57
$0.60
$0.72
-
Expected
$0.59
$0.57
$0.61
$0.57
$0.68
Surprise
6.17%
-0.29%
-1.64%
26.86%
-
Globus Medical News
AllArticlesVideos
Globus Medical Receives FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System
GlobeNewsWire·1 week ago
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
GlobeNewsWire·1 week ago
Globus Medical, Inc. (GMED) Q1 2024 Earnings Call Transcript
Seeking Alpha·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Globus Medical stock?
Globus Medical (GMED) has a market cap of $9.7B as of July 26, 2024.
What is the P/E ratio for Globus Medical stock?
The price to earnings (P/E) ratio for Globus Medical (GMED) stock is 131.97 as of July 26, 2024.
Does Globus Medical stock pay dividends?
No, Globus Medical (GMED) stock does not pay dividends to its shareholders as of July 26, 2024.
When is the next Globus Medical dividend payment date?
Globus Medical (GMED) stock does not pay dividends to its shareholders.
What is the beta indicator for Globus Medical?
Globus Medical (GMED) has a beta rating of 1.15. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Globus Medical stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.